🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are looking for other ways to treat pulmonary arterial hyperten...
Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 1930)
Start Date
2025-05-12
Trial ID
NCT06925750
Treatments Being Tested
The objective of this study is to evaluate the effects of sotatercept (MK-7...
Status
Completed
Location
Arizona Pulmonary Specialists ( Site 1010)
Start Date
2021-12-01
Trial ID
NCT04896008
Treatments Being Tested
This study is to evaluate the safety and tolerability of oxycodone control-...
Status
Completed
Location
Changhua Christian Hospital
Start Date
2016-10-31
Trial ID
NCT03176121
Treatments Being Tested
This study aims to evaluate the efficacy and safety of a continuous gastroc...
Status
Unknown
Location
Multiple Locations
Start Date
2022-07-14
Trial ID
NCT05463809
Treatments Being Tested
Pulmonary Arterial Hypertension (PAH) is a serious condition that puts stra...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-31
Trial ID
NCT07177703
Treatments Being Tested
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Ad...
Status
Terminated
Location
Site-501
Start Date
2024-10-23
Trial ID
NCT06493461
Treatments Being Tested
What is this study about? This study will test whether adding sotatercept t...
Status
Recruiting
Location
Kyushu University Hospital
Start Date
2025-10-07
Trial ID
NCT07356778
Treatments Being Tested
Study KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled...
Status
Terminated
Location
TROPOS Study Site 111
Start Date
2023-10-17
Trial ID
NCT05975905
Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2020-05-21
Trial ID
NCT04231448
RATIONALE: Morphine may reduce pain in patients who have undergone radiofre...
Status
Completed
Location
Institute Bergonié
Start Date
2007-12-24
Trial ID
NCT00712712